University Health Network Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
NCT Number: NCT00252447
Radical prostatectomy and radical radiation therapy remain the standard treatment approaches for patients with clinically localized prostate cancer (T1, T2).Radical prostatectomy is most effective when the disease is organ confined at the time of surgery. However, in many series up to 60% of patients have positive resection margins at the time of surgery and there is evidence to suggest that these patients may not be curable by surgery alone. A number of preoperative clinical variables including clinical stage, serum Prostate Specific Antigen (PSA) and Gleason scorea re helpful in determining the probability of finding organ confined disease at the time of syrgery.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Phase 1 / Phase 2
Toronto, Ontario, M5G 2M9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
University Health Network, Toronto
Other
A Pilot Study of Pre-Operative Conformal Radiotherapy in Patients With Radical Prostatectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03935282
Behavior, Breast Diseases
Fort Smith, Arkansas, United States
View Trial DetailsNCT01314118
Genital Diseases, Genital Diseases, Male
Homewood, Alabama, United States
View Trial DetailsNCT05162573
Genital Diseases, Genital Diseases, Male
Amsterdam, Netherlands
View Trial DetailsNCT03939689
Cancer of the Prostate, Castration-resistant Prostate Cancer
Duarte, California, United States
View Trial Details